bioRxiv · 10.1101/2020.10.06.327874
exosome-LncPICALM-AU1 regulates endothelial-mesenchymal transition in hepatopulmonary syndrome
Abstract
As important mediators of intercellular communication, exosome have can modulate various cellular functions by transferring a variety of intracellular components to target cells. However, little is known about the role of exosome-mediated communication between distant organs. Hepatopulmonary syndrome (HPS) is a severe lung injury caused by chronic liver disease. A new long noncoding RNA (lncRNA) PICALM-AU1 was found and upregulated in the liver of HPS. It was located in the cholangiocytes of liver and then, secreted as exosome into the serum. PICALM-AU1 carrying serum exosomes induced endothelial-mesenchymal transition (EndMT) of PMVECs and promoted lung injury in vivo and in vitro. Furthermore, overexpression of PICALM-AU1 significantly suppressed miR144-3p and subsequently induced ZEB1 expression. Taken together, our findings identified cholangiocyte-derived exosomal lncRNA PICALM-AU1 plays a critical role in the EndMT of HPS lung. And PICALM-AU1 represents a noninvasive biomarker and potential therapeutic target for HPS.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Yang, C., Yang, Y., Chen, Y., Huang, J., Li, Y., Zhi, H., Tang, X., Wang, X., Belguise, K., Xia, Z., Ning, J., Gu, J., Yi, B., lu, K.. 2020-10-09. exosome-LncPICALM-AU1 regulates endothelial-mesenchymal transition in hepatopulmonary syndrome. https://doi.org/10.1101/2020.10.06.327874
Cite the original work for its findings. Save a collection to share your selection of sources.